商务合作
动脉网APP
可切换为仅中文
DUBLIN--(BUSINESS WIRE)--The 'mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035: Distribution by Application Area, Target Disease Indication and Geographical Regions' report has been added to ResearchAndMarkets.com's offering.
都柏林——(商业新闻短讯)——ResearchAndMarkets.com的产品中增加了“到2035年mRNA疫苗和治疗市场行业趋势和全球预测:按应用领域、目标疾病适应症和地理区域的分布”报告。
The mRNA Vaccine and Therapeutics Market is valued at USD 9 billion in 2024 growing at a CAGR of 16% during the forecast period from 2026 to 2035.
2024年,mRNA疫苗和治疗剂市场价值为90亿美元,在2026年至2035年的预测期间,复合年增长率为16%。
Messenger ribonucleic acid (mRNA) is a form of single-stranded ribonucleic acid (RNA) that plays a crucial role in transferring genetic information necessary for protein synthesis. The instructions encoded in mRNA for producing proteins are relayed from a DNA strand to ribosomes, where they are translated into functional proteins.
信使核糖核酸(mRNA)是单链核糖核酸(RNA)的一种形式,在传递蛋白质合成所必需的遗传信息中起着至关重要的作用。在mRNA中编码的用于产生蛋白质的指令从DNA链传递到核糖体,在那里它们被翻译成功能性蛋白质。
The advent of mRNA therapeutics and vaccines has emerged as a groundbreaking alternative to traditional treatment methods. Following the COVID-19 pandemic, mRNA therapeutics and vaccines have gained substantial attention, establishing themselves as a revolutionary class of drugs for treating not only COVID-19 but also various other conditions, including infectious diseases, cancer, genetic disorders, and more..
mRNA疗法和疫苗的出现已成为传统治疗方法的突破性替代品。在新型冠状病毒肺炎大流行之后,mRNA疗法和疫苗受到了广泛关注,成为一类革命性的药物,不仅可以治疗新型冠状病毒肺炎,还可以治疗各种其他疾病,包括传染病、癌症、遗传疾病等。。
To date, four mRNA-based vaccines have received approval for COVID-19 treatment, with numerous additional candidates currently undergoing evaluation as potential therapies. The overall success of mRNA-based vaccines and therapies against COVID-19 has piqued the interest of many investors, particularly in small and emerging biotechnology companies focused on mRNA technology..
迄今为止,四种基于mRNA的疫苗已获得COVID-19治疗的批准,目前还有许多其他候选疫苗正在接受潜在疗法的评估。基于mRNA的新型冠状病毒疫苗和疗法的总体成功激起了许多投资者的兴趣,特别是专注于mRNA技术的小型和新兴生物技术公司。。
The achievements in mRNA therapeutics and vaccines have spurred increased research activity in the next-generation RNA therapeutics market. A robust pipeline of mRNA-based therapeutics and vaccines is also propelling growth in the mRNA synthesis and manufacturing sector, as drug developers seek contract services to scale up the production of mRNA-based treatments..
mRNA治疗和疫苗方面的成就刺激了下一代RNA治疗市场的研究活动。。。
Research Coverage:
研究范围:
A general introduction to mRNA, featuring insights on the historical evolution of mRNA therapeutics and vaccines. It also presents elaborate description on advantages associated with mRNA therapeutics and vaccines. It also features some of the key applications of both mRNA therapeutics and mRNA vaccines.
mRNA的一般介绍,重点介绍mRNA疗法和疫苗的历史演变。它还详细描述了与mRNA治疗和疫苗相关的优势。它还具有mRNA疗法和mRNA疫苗的一些关键应用。
Additionally, the chapter includes details on the various types of delivery routes and delivery strategies for mRNA drugs. Further, the chapter discusses the challenges associated with large scale adoption of mRNA therapeutics and vaccines and the associated future perspectives..
此外,本章还详细介绍了mRNA药物的各种递送途径和递送策略。此外,本章讨论了与大规模采用mRNA疗法和疫苗相关的挑战以及相关的未来前景。。
A detailed overview of the overall market landscape of mRNA therapeutics and vaccines, based on several relevant parameters, such as phase of development, type of drug candidate, therapeutic area, type of delivery system, type of molecule encoded and route of administration.
基于几个相关参数,例如开发阶段,候选药物类型,治疗区域,递送系统类型,编码分子类型和给药途径,详细概述了mRNA治疗剂和疫苗的总体市场前景。
A detailed overview of the current market of players engaged in the development of mRNA vaccine and therapeutics.
详细概述了目前从事mRNA疫苗和治疗剂开发的参与者市场。
An in-depth company competitiveness analysis of players in mRNA vaccine and therapeutics domain, based on their developer strength and number of therapeutic areas targeted.
根据开发人员的实力和目标治疗领域的数量,对mRNA疫苗和治疗领域的参与者进行深入的公司竞争力分析。
Elaborate profiles of key companies engaged in mRNA vaccine and therapeutics market. Each profile features a brief overview of the company, financial information, mRNA vaccines and therapeutics pipeline, recent developments and an informed future outlook.
详细介绍从事mRNA疫苗和治疗市场的关键公司。每个简介都简要介绍了该公司,财务信息,mRNA疫苗和治疗管道,最近的发展以及明智的未来前景。
A review of the various mRNA-focused initiatives undertaken by big pharma players, featuring a heat map representation that highlights mRNA therapeutics and vaccines under development, along with information on funding amount raised, partnership activity, and diversity of product portfolio, as well as a spider web representation, comparing the initiatives of big pharmaceutical players on the basis of multiple relevant parameters..
回顾了大型制药公司采取的各种以mRNA为重点的举措,其中重点介绍了正在开发的mRNA治疗和疫苗的热图表示,以及有关筹资金额,合作伙伴活动和产品组合多样性的信息,以及蜘蛛网表示,根据多个相关参数比较了大型制药公司的举措。。
An analysis of start-ups in this domain, based on several relevant parameters, such as number of candidates in discovery, preclinical and clinical phases of development. This chapter also provides details on amount raised, number of investors and number of deals inked.
基于几个相关参数对该领域的初创企业进行分析,例如发现中的候选人数量,临床前和临床开发阶段。本章还提供了融资金额、投资者数量和达成交易数量的详细信息。
An analysis of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines, based on several relevant parameters, such as trial registration year, trial status, trial phase, therapeutic area, study design, type of sponsor / collaborator, leading industry players, enrolled patient population and geography..
基于几个相关参数,如试验注册年份,试验状态,试验阶段,治疗领域,研究设计,赞助商/合作者类型,领先行业参与者,登记的患者人群和地理位置,对mRNA治疗和疫苗的已完成,正在进行和计划的临床研究进行分析。。
An analysis of recent collaborations and partnerships within the mRNA therapeutics and vaccines industry, based on several relevant parameters, such as year of partnership, type of partnership, therapeutic area, most active players and regional distribution of partnership activity that have been undertaken in this domain, since 2013..
基于几个相关参数,例如合作年份,合作类型,治疗领域,最活跃的参与者以及自2013年以来在该领域开展的合作活动的区域分布,对mRNA治疗和疫苗行业内最近的合作和伙伴关系进行了分析。。
A detailed analysis of various investments made by players in this domain, since 2013, based on several relevant parameters, such as year of funding, type of funding, amount invested, therapeutic area, most active players and key investors.
根据几个相关参数,如资金年份、资金类型、投资金额、治疗领域、最活跃的参与者和关键投资者,对2013年以来该领域参与者进行的各种投资进行了详细分析。
An in-depth analysis of the various patents that have been filed / granted related to mRNA therapeutics and vaccines domain, since 2016, based on several relevant parameters, such as type of patent, publication year, geographical region, CPC symbols, leading industry players and patent valuation.
根据几个相关参数,如专利类型,出版年份,地理区域,CPC符号,领先行业参与者和专利评估,对2016年以来提交/授予的与mRNA治疗和疫苗领域相关的各种专利进行了深入分析。
An in-depth analysis of the factors that can impact the growth of the market. It also features information on key drivers, potential restraints, emerging opportunities, and existing challenges within the mRNA vaccine and therapeutics market.
深入分析可能影响市场增长的因素。它还提供了有关mRNA疫苗和治疗市场内关键驱动因素,潜在限制,新兴机遇和现有挑战的信息。
A detailed mRNA vaccine and therapeutics market forecast analysis with our estimates of the existing market size, market value and future opportunity for mRNA vaccine and therapeutics companies over the next 11 years. Based on multiple parameters, likely adoption trends and through primary validations, we have provided an informed estimate on the market size during the forecast period 2024-2035..
详细的mRNA疫苗和治疗剂市场预测分析,以及我们对mRNA疫苗和治疗剂公司未来11年的现有市场规模,市场价值和未来机会的估计。根据多个参数、可能的采用趋势和初步验证,我们提供了2024-2035年预测期内市场规模的知情估计。。
Detailed projections of the current and future opportunity within the mRNA vaccine and therapeutics market across different application area, such as COVID-19 and other indications.
mRNA疫苗和治疗剂市场在不同应用领域(如COVID-19和其他适应症)的当前和未来机会的详细预测。
Detailed projections of the current and future opportunity within the mRNA vaccines & therapeutics market across different target disease indication, such as influenza, respiratory syncytial virus infection and cytomegalovirus diseases.
针对不同的目标疾病适应症(如流感,呼吸道合胞病毒感染和巨细胞病毒疾病),对mRNA疫苗和治疗市场当前和未来机会的详细预测。
Detailed projections of the current and future opportunity within the mRNA vaccine and therapeutics market across different geographical regions.
对不同地理区域mRNA疫苗和治疗剂市场当前和未来机会的详细预测。
Leading Market Companies
领先的市场公司
Arcturus Therapeutics
大角星疗法
BioNTech
BioNTech
CureVac
CureVac
Ethris
Ethris
IMMORNA
IMMORNA
Moderna
现代
Providence Therapeutics
普罗维登斯治疗学
RNACure
RNACure公司
Suzhou Abogen Biosciences
苏州阿博根生物科学
Turn Biotechnologies
转向生物技术
Gennova
Gennova
Innovac Therapeutics
Innovac Therapeutics公司
Kernal Biologics
核生物制剂
Pantherna Therapeutics
Pantherna疗法
pHion Therapeutics
pHion治疗学
Recode Therapeutics
Recode治疗学
Rejuvenation Technologies
复兴技术
RNAimmune
RN上一页
Strand Therapeutics
链疗法
Walvax
瓦尔瓦
Ziphius Vaccines
Ziphius疫苗
Key Topics Covered:
涵盖的关键主题:
1. PREFACE
1、前言
2. RESEARCH METHODOLOGY
2、研究方法
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
经济和其他项目特定考虑因素
3.1. Chapter Overview
三点一。章节概述
3.2. Market Dynamics
三点二。
4. EXECUTIVE SUMMARY
4、执行摘要
5. INTRODUCTION
5、简介
5.1. Chapter Overview
5.1条。章节概述
5.2. mRNA Therapeutics
五点二。mRNA治疗学
5.3. mRNA Vaccines
五点三。mRNA疫苗
5.4. mRNA Delivery Routes
五点四。mRNA传递途径
5.5. mRNA Delivery Strategies
五点五。mRNA传递策略
5.6. Key Challenges Associated with mRNA Vaccine and Therapeutics
五点六。与mRNA疫苗和治疗相关的关键挑战
5.7. Future Perspectives
五点七。未来展望
6. MARKET LANDSCAPE
6、市场格局
6.1. Chapter Overview
六点一。章节概述
6.2. mRNA Vaccine and Therapeutics: Overall Market Landscape
六点二。mRNA疫苗和疗法:总体市场前景
7. COMPETITIVE LANDSCAPE
7、竞争格局
7.1. Chapter Overview
7.1条。章节概述
7.2. mRNA Vaccine and Therapeutics: List of Developers
七点二。mRNA疫苗和疗法:开发人员名单
8. COMPANY COMPETITIVENESS ANALYSIS
8、公司竞争力分析
8.1. Chapter Overview
8.1条。章节概述
8.2. Key Assumptions and Parameters
八点二。关键假设和参数
8.3. Methodology
八点三。方法论
8.4. mRNA Vaccine and Therapeutics Developers: Company Competitiveness Analysis
。mRNA疫苗和治疗剂开发商:公司竞争力分析
8.5. mRNA Vaccine and Therapeutics Developers based in North America
八点五。北美的mRNA疫苗和治疗开发人员
8.6. mRNA Vaccine and Therapeutics Developers based in Europe
八点六。基于欧洲的mRNA疫苗和治疗开发人员
8.7. mRNA Vaccine and Therapeutics Developers based in Asia-Pacific and Rest of the World
八点七。亚太地区和世界其他地区的mRNA疫苗和治疗开发人员
9. COMPANY PROFILES
9、公司简介
Leading Companies in mRNA Vaccine and Therapeutics Market
mRNA疫苗和治疗剂市场的领先公司
Arcturus Therapeutics
大角星疗法
BioNTech
BioNTech
CureVac
CureVac
Ethris
Ethris
Immorna
Immorna
Moderna
现代
Providence Therapeutics
普罗维登斯治疗学
Suzhou Abogen Biosciences
苏州阿博根生物科学
Other Leading Players in mRNA Vaccine and Therapeutics Market
mRNA疫苗和治疗剂市场的其他主要参与者
Gennova Biopharmaceuticals
Gennova生物制药
Innovac Therapeutics
Innovac Therapeutics公司
Kernal Biologics
核生物制剂
Pantherna Therapeutics
Pantherna疗法
pHion Therapeutics
pHion治疗学
Recode Therapeutics
Recode治疗学
Rejuvenation Technologies
复兴技术
RNACure
RNACure公司
RNAimmune
RN上一页
Strand Therapeutics
链疗法
Turn Biotechnologies
转向生物技术
Walvax
瓦尔瓦
Ziphius Vaccines
Ziphius疫苗
10. BIG PHARMA INITIATIVES
10、大型制药项目
10.1. Chapter Overview
10.1条。章节概述
10.2. Scope and Methodology
10.2条。范围和方法
10.3. mRNA Related Initiatives of Big Pharmaceutical Players
10.3条。大型制药企业的mRNA相关举措
10.4. Benchmarking Analysis: Big Pharma Players
。基准分析:大型制药公司
Amgen
安进
AstraZeneca
阿斯利康
Bayer
拜耳
BioNTech
BioNTech
Eli Lilly
礼来
Gilead Sciences
吉利德科学
GlaxoSmithKline
葛兰素史克
Merck
默克公司
Moderna
现代
Novartis
诺华公司
Novo Nordisk
诺和诺德
Pfizer
辉瑞公司
Roche
罗氏公司
Sanofi
赛诺菲
Takeda
塔克达
11. START-UP HEALTH INDEXING
11、启动健康指数
11.1. Chapter Overview
11.1条。章节概述
11.2. Start-ups focused on mRNA Vaccine and Therapeutics
11.2条。专注于mRNA疫苗和治疗的初创公司
11.3. Benchmarking of Start-ups
11.3条。初创企业的标杆管理
11.4. Startup-Health Indexing
11.4条。启动运行状况索引
12. CLINICAL TRIAL ANALYSIS
12、临床试验分析
12.1. Chapter Overview
12.1条。章节概述
12.2. Scope and Methodology
十二点二。范围和方法
12.3. mRNA Vaccine and Therapeutics: Clinical Trial Analysis
12.3条。mRNA疫苗与治疗:临床试验分析
13. PARTNERSHIPS AND COLLABORATIONS
13、伙伴关系与合作
13.1. Chapter Overview
13.1条。章节概述
13.2. Partnership Models
13.2条。合作模式
13.3. mRNA Vaccine and Therapeutics: Partnerships and Collaborations
13.3条。mRNA疫苗和治疗:伙伴关系和合作
14. FUNDING AND INVESTMENT ANALYSIS
14、资金和投资分析
14.1. Chapter Overview
14.1条。章节概述
14.2. Types of Funding
14.2条。资金类型
14.3. mRNA Vaccine and Therapeutics: Funding and Investments
14.3条。mRNA疫苗和治疗:资金和投资
15. PATENT ANALYSIS
15、专利分析
15.1. Chapter Overview
15.1条。章节概述
15.2. Scope and Methodology
15.2条。范围和方法
15.3. mRNA Vaccine and Therapeutics: Patent Analysis
15.3条。mRNA疫苗和治疗:专利分析
15.4. Patent Benchmarking Analysis
15.4条。专利标杆分析
15.5. mRNA Vaccine and Therapeutics: Patent Valuation Analysis
15.5条。mRNA疫苗和治疗:专利评估分析
16. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
16、市场影响分析:驱动因素、制约因素、机遇和挑战
17. GLOBAL mRNA VACCINE AND THERAPEUTICS MARKET
全球mRNA疫苗和治疗剂市场
17.1. Chapter Overview
17.1条。章节概述
17.2. Assumptions and Methodology
。假设和方法
17.3. Global mRNA Vaccine and Therapeutics Market, till 2035
17.3条。全球mRNA疫苗和治疗市场,至2035年
18. mRNA VACCINE AND THERAPEUTICS MARKET, BY APPLICATION AREA
mRNA疫苗和治疗剂市场,按应用领域
18.1. Chapter Overview
18.1条。章节概述
18.2. Key Assumptions and Methodology
18.2条。关键假设和方法
18.3. mRNA Vaccine and Therapeutics Market: Distribution by Application Area, 2024, 2028 and 2035
18.3条。mRNA疫苗和治疗剂市场:2024、2028和2035年按应用领域分布
19. mRNA VACCINE AND THERAPEUTICS MARKET, BY TARGET DISEASE INDICATION
19.1. Chapter Overview
19.1条。章节概述
19.2. Key Assumptions and Methodology
19.2条。关键假设和方法
19.3. mRNA Vaccine and Therapeutics Market: Distribution by Target Disease Indication, 2026, 2030 and 2035
19.3条。mRNA疫苗和治疗剂市场:2026年、2030年和2035年按目标疾病指征的分布
20. mRNA VACCINE AND THERAPEUTICS MARKET, BY GEOGRAPHICAL REGIONS
mRNA疫苗和治疗剂市场,按地理区域划分
20.1. Chapter Overview
20.1条。章节概述
20.2. Key Assumptions and Methodology
20.2条。关键假设和方法
20.3. mRNA Vaccine and Therapeutics Market: Distribution by Geographical Regions, 2020, 2024 and 2035
20.3条。mRNA疫苗和治疗剂市场:2020年、2024年和2035年按地理区域分布
For more information about this report visit https://www.researchandmarkets.com/r/42swfq
有关此报告的更多信息,请访问https://www.researchandmarkets.com/r/42swfq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。